APR 30, 2019 12:05 PM PDT

Using a popular anti-smoking drug to control brain cells

Designer receptors exclusively activated by designer drugs, or simply called designer receptors, are specially engineered proteins that are used to control the activity of neurons. Specific drugs bind very precisely to the receptors to turn them on, similar to a lock-and-key mechanism, and this causes an increase or decrease in neural activity of the cell. By placing these receptors only in certain groups of neurons, scientists can very precisely control this group of cells while leaving other cells unperturbed.

For two decades, this method, called chemogenetics, has worked exceptionally well to control neurons in rodents, and more recently in non-human primates, for research applications. Scientists have spent years matching drugs with receptors to achieve precise and effective combinations, yet making this technology feasible for clinical use in humans has been challenging.

Other scientists working on this approach "often use molecules that would not be appropriate for human therapy," Sternson says. "It's still many steps to the clinic, but we're trying to shorten that route."

Rather than creating a new drug, Scott Sternson, a group leader at the Howard Hughes Medical Institute's Janelia Research Campus, took a different approach by sifting through existing FDA-approved drugs, and upon finding a viable candidate, tweaked the structure of the drug's receptor.

Sternson and his team decided on varenicline (i.e. Chantix(R)), a commonly prescribed drug that reduces nicotine cravings. Then, the research group modified the structure of two ion channel proteins to make varenicline bind extremely well to the receptor. One receptor makes neurons more active, and another shuts them down or silences cells when the drug is on board, just like traditional designer receptors. The best part about the drug? It can be used in ultralow doses to control neurons, which means less unwanted side effects in people.

Photo source: Forbes/ Bloomberg

"These are the most potent chemogenetic receptors described so far," Sternson says. Even low doses of varenicline -- well below the level used for smoking cessation -- can have a big effect on neural activity. 

In the lab, chemogenetics is widely used by neuroscientists to study how neural activity is related to animal behavior. Sternson and his team, however, seek to use chemogenetics to treat human diseases. The ability to turn specific cells on or off with precision is the future of therapeutics. For example, Sternson believes the technology may be used to treat pain by targeting only injured parts of the body. This is important for reducing the incidence of addiction to pain killers. Another example is severe epilepsy. Rather than surgically remove parts of the brain associated with seizures, designer receptors can be placed into neurons in these regions and patients could take a drug that targets and/ or regulates these specific cells.

Source: ScienceDaily

About the Author
You May Also Like
SEP 28, 2021
Immunology
Caught on Tape: Immune Cells Migrating From the Gut to the Brain
SEP 28, 2021
Caught on Tape: Immune Cells Migrating From the Gut to the Brain
A team of immunologists has taken the first glimpse at a never-before-seen migratory path of immune cells from the gut a ...
OCT 07, 2021
Neuroscience
Unclogged: Constipation Drug May Stimulate Memory and Cognition
OCT 07, 2021
Unclogged: Constipation Drug May Stimulate Memory and Cognition
A drug commonly prescribed for constipation shows promise for memory and cognition
OCT 19, 2021
Health & Medicine
Acupuncture and Manual Therapy for Tension Headache: What's the Verdict?
OCT 19, 2021
Acupuncture and Manual Therapy for Tension Headache: What's the Verdict?
As if women didn't have enough to juggle with careers, motherhood, and monthly hormonal changes, cue the tension hea ...
NOV 05, 2021
Cannabis Sciences
Advances in Medical Cannabis for Treating Autism Spectrum Disorder
NOV 05, 2021
Advances in Medical Cannabis for Treating Autism Spectrum Disorder
Encouraging clinical evidence has recently sparked an emerging interest in the use of CBD-enriched medical cannabis as a ...
NOV 11, 2021
Technology
Chatty Chatbots Learn to Cope with Figurative Language
NOV 11, 2021
Chatty Chatbots Learn to Cope with Figurative Language
Researchers investigate methods to improve dialogue system engagement with natural language
NOV 29, 2021
Cell & Molecular Biology
Researchers Discover a New Type of Cell in the Retina
NOV 29, 2021
Researchers Discover a New Type of Cell in the Retina
Many types of cells in the eye were identified 100 years ago. But researchers found something new there.
Loading Comments...